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he development of immune defense mecha-
nisms begins early during fetal life but is not
completely achieved at birth, leading to a peculiar
susceptibility of the neonate to infectious dis-
eases. 1,z The earliest hematopoietic stem cells are
detectable in the yolk sac around 6 weeks of ges-
tation, but at that time they are only able to differ-
entiate into myelomonocytic cells. Thereafter, the
hematopoiesis takes place in the liver from the 7th
week of gestation until the 6th month, thereafter in
the bone-marrow. A unique precursor is at the ori-
gin of all hematopoitic cell lines.
NORMAL SPECIFIC IMMUNITY
DEVELOPMENT
A schematic representation of the T and B lym-
phocyte differentiation is shown in Figure 1.
Cellular Immunity
Lymphoid cells with the surface phenotype of
pro-T (CD7+) are found in the fetal liver by 7
weeks of gestation, and the fetal thymus is colo-
nized by 8.5 weeks of gestation. Pro-T cells (from
fetal liver in early gestation, thereafter from bone-
marrow) are attracted into the thymus by chemo-
tactic agents secreted by thymic epithelial cells.3
Shortly after, thymocytes express the marker CD2,
as well as both markers CD4 and CD8 (pre-T
cells). Then, the pre-T cells acquire the specific
T-cell antigen receptor (TCR) associated with the
complex CD3 and express either CD4 or CD8 mol-
ecules (mature T cells). The TCR which results
from stochastic gene rearrangements specifically
recognizes antigenic peptides which have been
processed by antigen presenting cells only if pre-
sented by self HLA molecules; the diversity of the
TCR repertoire is progressively acquired by posi-
tive (leading to amplification of T-cell clones able
to recognize foreign antigens) and negative (allow-
ing the destruction of autoreactive T-cell clones)
selection mechanisms occuring in the thymus by
close contact of pre-T lymphocytes with dendritic
and epithelial cells.4,s Mature CD4+ T cells recog-
nize by their TCR foreign antigenic peptides pre-
sented by HLA class II molecules, expressed on B
cells and monocytes, and, by the way, are essen-
tially helper T cells; in contrast, mature CD8+ T
cells recognize foreign antigenic peptides pre-
sented by HLA class I molecules and, thus, are
essentially cytotoxic/suppressor T cells. CD4+ T
cells represent 65% and CD8+ 35% of mature
(CD3+) T cells. Mature T cells are able to go out of
the thymus, to circulate in the blood and to reach
the lymphoid organs (spleen and lymph nodes) in
which the immune response occurs.
By 13 weeks of gestation, each of the major T-
cell subsets are present in cord blood and normally
functional for mitogenic and allogeneic-stimula-
tion.6 However, fetal and neonatal T cells are vir-
gin T cells because of the lack of prior exposure to
antigen; this status explains the selective impair-
ment of lymphokine production which likely con-
tributes to the immune deficiency observed during
the neonatal period: contrasting with a normal pro-
duction of IL2, the production of other cytokines
arc either moderately (TNFa, GM-CSF) or mark-
edly reduced (IL-3, IL-4, IL-5, IFNy).7-1 More-
over, neonatal T lymphocytes are less efficient for
B cell help to immunoglobulin (Ig) synthesis, likely
because of an impaired expression of the T-cell
activation marker CD40-1igand. During fetal life,
infections can also occur when TCR repertoire is
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Fig. I. Normal differentiation of T and B lymphocytes.
still limited; this situation can explain the severity
of in utero early infections by Toxoplasma gondii or
CMV.z
Humoral ImmuniW
Precursors of B cells are first detected in fetal liver
at 8 weeks of gestation and thereafter in bone-
marrow.The maturation of pre-B cells into mature
B cells occur in these hematopoietic organs. Imma-
ture B cells expressing a surface immunoglobulin
(the B Cell Receptor or BCR) of the IgM isotype
are detected at 12 weeks of gestation, lz As for T
cells, the diversity of the BCR repertoire is pro-
gressively acquired with positive and negative (de-
letion of auto-reactive B cells) selection mecha-
nisms occuring in the bone-marrow. The main dif-
ference between TCR and BCR is the fact that
BCR can recognize native antigens (and not pro-
cessed antigenic peptides) without any interaction
with HLA molecules. The mature B cell bearing
on its membrane IgM+IgD leaves the bone-mar-
row and reaches the spleen and lymph nodes in
which the immune response occurs. In germinal
centers of lymphoid organs, other mechanisms take
place, requiring a close relation with T cells: the
immunoglobulin switching which allows a B cell to
produce an immunoglobulin IgG, IgA or IgE with
the same antigen specificity as the IgM previously
produced and the positive selection of high affinity
BCR bearing 13 cells.
Although specific antibody synthesis, essentially
of the IgM isotype, is detectable as early as 20-24
weeks of gestation in an infected fetus, little IgM
and IgA are present in the healthy neonate because
of the lack of antigen exposure in normal condi-
tions, and IgG is only from maternal origin (the
transplacental transfer progressively increases from
the 6th month of gestation). Immunoglobulin lev-
els increase progressively to reach adult levels at 4
years of life. The neonate is able to produce spe-
cific antibodies to protein antigens but at a lesser
degree than adults. This impaired response is
likely related to the virgin status of B cells and to a
defect in T-B cell cooperation. The response of
infants to polysaccharidic antigens, a response
which is supposed to be less T-cell dependent than
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the response to protein antigens, is severely im-
paired during the two first years of life. 13
NONSPECIFIC IMMUNITY DEVELOPMENT
Natural Killer Activity
Cells with a Natural Killer (NK) phenotype are
detected as early as 6 weeks of gestation in the fetal
liver. NK activity increases progressively during fe-
tal life; it is about 50% of adult NK activity at birth
and reaches normal values at age of 4 years. 14
Antigen Presenting Cells
Macrophages are detectable very early (4 weeks of
gestation) in the yolk sac and found in lymphoid
organs at 13 weeks. However, at birth, their num-
ber in tissues appears reduced, especially in the
lungs. This can be related to an impaired chemo-
taxis. The production of monokines has been re-
ported as normal (IL-1) or slightly diminished (IL-
6, TNFo and IL-8). The processing of native an-
tigens and presentation to T cells are also effi-
cient, is
Polymorphonuclear Cells
The most obvious defect is the diminished storage
pool and the impaired delivery of polymorpho-
nuclear cells at sites of infections, a defect which
can be reported to an impaired chemotaxis. Neu-
trophils precursors are first detected in the yolk sac
at 6 weeks of gestation, then in the liver and bone-
marrow. Functional mature polymorphonuclear
cells are present at 12-14 weeks of gestation but
represent a very low percentage of circulating
white blood cells. Their number sharply increases
after birth; however, preterm or severely infected
neonates often present with a severe neutrope-
nia. 16
Complement System
Synthesis of the different components of comple-
ment begins at the 8th week of gestation and pro-
gressively increases until birth. At that time, levels
of the different factors are around 50% of adult
values. 17
IMMUNE DEFICIENCIES
Acquired Immunodeficiencies
Most of the abnormalities impairing the fetal im-
mune system development are acquired in utero. It
is especially the case for infections occuring during
pregnancy, such as rubella, cytomegaolovirus
(CMV) or human immunodeficiency virus (HIV).
In these situations, T cells are defective both in
their number and in their function.
Preterm neonates also present with a severe, but
transitory, immune deficiency charaterized by a hy-
pogammaglobulinemia, a neutropenia and a defect
of the different complement factors.
An alloimmunisation of the mother directed
against paternal antigens present on fetal polymor-
phonuclear cells may result in a severe, but transi-
tory, neutropenia.
Finally, a defect of humoral immunity in the
mother will result in a transitory hypogammaglobu-
linemia in the neonate.
Inherited Immune Deficiencies
Specific Immunity Deficiencies
Numerous blockades can occur on the maturation
pathway of T and/or B lymphocytes resulting in
different inherited immunedcficiencies (Figure 2):
a A defect of the lymphoid precursor results in a
complete lack ofT and B lymphocytes leading to a
severe combined immunodeficiency (SCID), the
transmission of which is autosomal recessive. An
enzymatic defect (deficiency in the adenosine de-
saminase, an enzyme necessary for purine metabo-
lism, the gene of which is located on chromosome
20) is found in around 50% of cases,a
b In other cases, a defect of enzymes involved in
TCR or Ig gene recombination is suspected.9
c A selective defect of the T-cell precursors is
defined by a complete absence of T lymphocytes
with normal B cells. However, the B cells cannot
produce antibodies without T-cell help. Thus, this
immune deficiency is a SCID. One form is due to
a mutation of the gene coding for a chain (the g
chain) of several receptors for lymphokines in-
volved in T-cell differentiation. This gene is lo-
cated on chromosome X.z Another form, autoso-
mal recessive, is secondary to a defect of an en-
zyme (jak3) which is known to transmit intracellu-
lar signals of the g chain,z
d Other abnormalities can occur on the T-cell
maturation pathway, including the defect of thy-
mus. This immune deficiency, called Di George
syndrome, is characterised by a complete absence
ofT cells (resulting in SCID) when the thymus is
absent or by a partial T-cell defect in incomplete
forms. The immune deficiency is associated with
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Fig. 2. Arrests of maturation of T and B lymphocytes.
cardiopathy and hypoparathyroidism. The mode of
transmission is autosomal dominant, and a micro-
deletion of chromosome 22 is constantly found,zz
e, f Other abnormalities can also impair T-cell
immunity development or function, as observed in
defective expression of membrane antigens, result-
ing in combined immunodeficiencies: indeed, the
defect in the T-cell pathway induces a secondary B
cell deficiency. For example, in the X-linked
hyper-IgM syndrome, a defect of expression of the
molecule CD40-1igand on activated T cells (=f) re-
sults in a complete lack of immunoglobulin switch-
ing.2s g The B cell maturanon pathway can also
be affected, leading to a humoral immune defect.
The best known is the X-linked agammaglobulin-
emia secondary to an early blockade on B lympho-
cyte differenciation. This abnormality has been re-
ported to a defect in an enzyme (btk) necessary for
B cell development.24
Two genes responsible when mutated for rela-
tively frequent and severe immune deficiencies
have been recently cloned: on X chromosome, the
gene responsible for the Wiskott-Aldrich syndrome
which associates an immune deficiency, eczema
and thrombopenia (=h)zs and on chromosome 11
the gene responsible for ataxia telangiectasia char-
acterised by a T-cell defect and progressive neuro-
logical problems,z6
Nonspecific Immunity Deficiencies
Inherited defects can also impair nonspecific im-
munity: the chronic granulomatous disease is due
to a genetic defect of cytochrome b involved in
oxydative metabolism of polymorphonuclear
cells. This disease is either X-linked or autosomal
recessive, depending of the affected chain of cyto-
chrome b.27
Other defects can affect the complement fac-
tors.
The recent cloning of different genes involved
in maturation or function of specific or nonspecific
immune cells has greatly improved our understand-
ing of development of the immune system in nor-
mal human fetuses and neonates. In pathological
conditions, this genetic approach allows a greater
accuracy in postnatal diagnosis and is peculiarly
useful for prenatal diagnosis. It also opens the way
for gene therapy in the near future.
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